The author replies

New England Journal of Medicine

Volumn 370, Issue 22, 2014, Pages 2153-

  Hunt, Beverley J ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

BLOOD CLOTTING DISORDER; CD4 LYMPHOCYTE COUNT; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME DEFICIENCY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; LETTER; MORTALITY; PARTIAL THROMBOPLASTIN TIME; PATIENT CARE; POINT OF CARE TESTING; PRIORITY JOURNAL; PROGNOSIS; PROTHROMBIN TIME; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 84901796077     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1403768     Document Type: Letter

References (5)

1. Scully M, Hunt BJ, Benjamin S, et al. Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol 2012;158:323-35.
2. Ross CL, Hunt BJ, Wyncoll D, Hodgkiss A, Peters B. HIV, thrombotic thrombocytopaenic purpura and rituximab in a violent noncompliant patient. Blood Coagul Fibrinolysis 2009;20:157-60.
3. Adamzik M, Görlinger K, Peters J, Hartmann M. Whole blood impedance aggregometry as a biomarker for the diagnosis and prognosis of severe sepsis. Crit Care 2012;16:R204.
4. Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion. Cochrane Database Syst Rev 2011;3:CD007871.
5. Müller MC, Meijers JC, Vroom MB, Juffermans NP. Utility of thromboelastography and/or thromboelastometry in adults with sepsis: a systematic review. Crit Care 2014;18:R30.